Van Daele, R.; Wauters, J.; Lagrou, K.; Denooz, R.; Hayette, M.-P.; Gijsen, M.; Brüggemann, R.J.; Debaveye, Y.; Spriet, I.
Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients. Microorganisms 2021, 9, 2068.
https://doi.org/10.3390/microorganisms9102068
AMA Style
Van Daele R, Wauters J, Lagrou K, Denooz R, Hayette M-P, Gijsen M, Brüggemann RJ, Debaveye Y, Spriet I.
Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients. Microorganisms. 2021; 9(10):2068.
https://doi.org/10.3390/microorganisms9102068
Chicago/Turabian Style
Van Daele, Ruth, Joost Wauters, Katrien Lagrou, Raphaël Denooz, Marie-Pierre Hayette, Matthias Gijsen, Roger J. Brüggemann, Yves Debaveye, and Isabel Spriet.
2021. "Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients" Microorganisms 9, no. 10: 2068.
https://doi.org/10.3390/microorganisms9102068
APA Style
Van Daele, R., Wauters, J., Lagrou, K., Denooz, R., Hayette, M.-P., Gijsen, M., Brüggemann, R. J., Debaveye, Y., & Spriet, I.
(2021). Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients. Microorganisms, 9(10), 2068.
https://doi.org/10.3390/microorganisms9102068